Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time
07:30am, Wednesday, 04'th Sep 2024
NEW YORK , Sept. 4, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host its Investor Day today in New York.
Bet on These 5 Stocks With Upgraded Broker Ratings Right Now
09:22am, Monday, 02'nd Sep 2024
Brokers have deeper insights into stocks and the macroeconomic backdrop. One must follow broker rating upgrades to pick stocks like WWW, BMRN, DDOG, PGR & KVYO.
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock
10:51am, Thursday, 29'th Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SAN RAFAEL, Calif. , Aug. 29, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin will pr
BioMarin to reduce global workforce by about 225 employees
05:32pm, Wednesday, 28'th Aug 2024
BioMarin Pharmaceutical will reduce its global workforce by about 225 employees, a filing showed on Wednesday.
Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Wednesday, 28'th Aug 2024
BioMarin (BMRN) possesses solid growth attributes, which could help it handily outperform the market.
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
10:46am, Wednesday, 28'th Aug 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is the Options Market Predicting a Spike in BioMarin (BMRN) Stock?
09:01am, Friday, 23'rd Aug 2024
Investors need to pay close attention to BioMarin (BMRN) stock based on the movements in the options market lately.
BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024
04:21pm, Wednesday, 21'st Aug 2024
BioMarin Pharmaceutical Inc. sales of Voxzogo had increased by 62% to $184 million in Q2 of 2024, compared to the same period in 2023. Potential to eventually expand the use of Voxzogo towards other i
BioMarin Announces New R&D and Business Development Leadership
08:30am, Wednesday, 21'st Aug 2024
Greg Friberg, M.D., Appointed EVP, Chief Research & Development Officer as Hank Fuchs, M.D.
BioMarin to Host 2024 Investor Day on September 4th in New York
09:00am, Monday, 19'th Aug 2024
- Event to be webcast live and a replay will be available SAN RAFAEL, Calif. , Aug. 19, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host an Investor Day with financial analy
Here's Why You Should Invest in BioMarin (BMRN) Stock Now
11:36am, Tuesday, 13'th Aug 2024
Here, we are discussing some reasons why investing in BioMarin (BMRN) stock now may turn out to be a prudent move.
Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term
10:50am, Tuesday, 13'th Aug 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
BioMarin (BMRN) is an Incredible Growth Stock: 3 Reasons Why
01:50pm, Monday, 12'th Aug 2024
BioMarin (BMRN) could produce exceptional returns because of its solid growth attributes.
Rare Disease-Focused BioMarin Narrows Sales Focus, Cuts Cost For Hemophilia A Gene Therapy; Lifts Annual Guidance
03:06pm, Tuesday, 06'th Aug 2024
BioMarin Pharmaceutical Inc. BMRN announced an update on its Roctavian business to focus commercial operations on three markets: the U.S., Germany and Italy.
